FI20002693L - Menetelmä karboksyylihappojen valmistamiseksi - Google Patents

Menetelmä karboksyylihappojen valmistamiseksi Download PDF

Info

Publication number: FI20002693L
Authority: FI; Finland
Prior art keywords: carboxylic acids; preparing carboxylic; preparing; acids; carboxylic
Prior art date: 1994-10-04

Application number

FI20002693A

Other languages

English (en)

Swedish (sv)

Other versions

FI108791B (fi

Inventor

Ulrich Mueller

Richard Connell

Siegfried Goldmann

Rudi Gruetzmann

Martin Beuck

Hilmar Bischoff

Dirk Denzer

Anke Domdey-Bette

Stefan Wohlfeil

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

2000-12-08

Publication date

2000-12-08

2000-12-08 Application filed by Bayer Ag filed Critical Bayer Ag

2000-12-08 Publication of FI20002693L publication Critical patent/FI20002693L/fi

2002-03-28 Application granted granted Critical

2002-03-28 Publication of FI108791B publication Critical patent/FI108791B/fi

Links

150000001735 carboxylic acids Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

FI20002693A 1994-10-04 2000-12-08 Menetelmä karboksyylihappojen valmistamiseksi FI108791B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4435477		1994-10-04
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (2)

Publication Number	Publication Date
FI20002693L true FI20002693L (fi)	2000-12-08
FI108791B FI108791B (fi)	2002-03-28

Family

ID=6529939

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI954681A FI113048B (fi)	1994-10-04	1995-10-02	Karboliini- ja karbatsolijohdannaisia, menetelmä niiden valmistamiseksi ja menetelmässä käytettäviä välituotteita
FI20002693A FI108791B (fi)	1994-10-04	2000-12-08	Menetelmä karboksyylihappojen valmistamiseksi

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FI954681A FI113048B (fi)	1994-10-04	1995-10-02	Karboliini- ja karbatsolijohdannaisia, menetelmä niiden valmistamiseksi ja menetelmässä käytettäviä välituotteita

Country Status (35)

Country	Link
US (6)	US5684014A (fi)
EP (1)	EP0705831B1 (fi)
JP (1)	JP3901234B2 (fi)
KR (1)	KR100355986B1 (fi)
CN (2)	CN1183111C (fi)
AT (1)	ATE255580T1 (fi)
AU (1)	AU700609B2 (fi)
CA (1)	CA2159546C (fi)
CZ (1)	CZ291348B6 (fi)
DE (2)	DE4435477A1 (fi)
DK (1)	DK0705831T3 (fi)
DZ (1)	DZ1934A1 (fi)
EE (1)	EE03527B1 (fi)
ES (1)	ES2211890T3 (fi)
FI (2)	FI113048B (fi)
HN (1)	HN1995009160A (fi)
HR (1)	HRP950505B1 (fi)
HU (1)	HU225052B1 (fi)
IL (3)	IL129641A0 (fi)
MA (1)	MA23683A1 (fi)
MY (1)	MY117282A (fi)
NO (1)	NO305365B1 (fi)
NZ (1)	NZ280130A (fi)
PH (1)	PH31400A (fi)
PL (1)	PL183154B1 (fi)
PT (1)	PT705831E (fi)
RU (1)	RU2157803C2 (fi)
SG (1)	SG63528A1 (fi)
SI (1)	SI0705831T1 (fi)
SK (1)	SK284260B6 (fi)
SV (1)	SV1995000062A (fi)
TN (1)	TNSN95098A1 (fi)
TW (1)	TW448175B (fi)
UA (1)	UA44700C2 (fi)
ZA (1)	ZA958297B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19615119A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) *	1996-04-17	1997-10-22	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
CN1303290A (zh) *	1998-05-01	2001-07-11	伊莱利利公司	sPLA2抑制剂酯
ES2213984T3 (es)	1998-10-30	2004-09-01	Eli Lilly And Company	Derivados de azaindol y su uso como agentes antitrombicos.
AU4616200A (en) *	1999-05-25	2000-12-12	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
MEP28108A (en) *	2000-03-15	2010-10-10	Sanofi Aventis Deutschland	Substituted beta-carbolines with ikb-kinase inhibiting activity
EP1134221A1 (en) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Substituted beta-carbolines as lkB kinase inhibitors
AU2001244635A1 (en) *	2000-03-30	2001-10-15	Yamanouchi Pharmaceutical Co..Ltd.	Hydrazide derivatives
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
CA2672805A1 (en) *	2001-01-31	2002-08-08	H. Lundbeck A/S	Pyrimidine derivatives
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
CN1630629B (zh) *	2002-02-28	2010-05-05	日本烟草产业株式会社	酯化合物及其医药用途
JPWO2003101983A1 (ja) *	2002-05-31	2005-09-29	アステラス製薬株式会社	テトラヒドロピラン誘導体
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
WO2004063156A1 (en) *	2003-01-08	2004-07-29	Biovitrum Ab	Novel indole derivates as fabp-4 inhibitors
WO2005051382A1 (ja) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	脂質低下作用増強剤
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
NZ549721A (en)	2004-03-05	2010-08-27	Univ Pennsylvania	Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
US20080280922A1 (en) *	2004-04-09	2008-11-13	Marc Alois Celine Maria Engelen	Intermittent Dosing Regimen For Overweight and Obese Subjects
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
BRPI0516772A (pt) *	2004-10-25	2008-09-23	Japan Tobacco Inc	formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
JP2008542255A (ja) *	2005-05-27	2008-11-27	ファイザー・プロダクツ・インク	肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
WO2007015162A1 (en) *	2005-08-04	2007-02-08	Pfizer Limited	Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
JP2009511635A (ja) *	2005-10-18	2009-03-19	エージェリオンファーマシューティカルズ	哺乳動物における高脂血症に関連する障害を治療するための方法
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
AP2008004602A0 (en) *	2006-02-23	2008-10-31	Pfizer Ltd	Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US20080051427A1 (en) *	2006-05-18	2008-02-28	Fritz Schuckler	Pharmaceutical Compositions and Methods of Using Same
CA2669311C (en)	2006-11-13	2011-09-20	Pfizer Products Inc.	Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
JP5498168B2 (ja)	2006-12-01	2014-05-21	ブリストル−マイヤーズスクイブカンパニー	アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
US20080161279A1 (en) *	2006-12-21	2008-07-03	Wisler Gerald L	Methods of Treating Obesity
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (en) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
CA2731897C (en) *	2008-08-06	2013-07-02	Pfizer Limited	Diazepine and diazocane compounds as mc4 agonists
CN113416187B (zh)	2013-03-14	2024-07-19	奥斯菲治疗有限公司	促进骨生长的烷基胺骆驼蓬碱衍生物
AU2015311730A1 (en) *	2014-09-05	2017-04-20	Allosteros Therapeutics, Inc	Camkii inhibitors and uses thereof
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560B (zh)	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
JP7695496B2 (ja)	2018-08-14	2025-06-19	オシフィセラピューティクスリミティドライアビリティカンパニー	フルオロβ－カルボリン化合物
ES3004565T3 (en)	2018-08-14	2025-03-12	Ossifi Therapeutics Llc	Pyrrolo - dipyridine compounds for the treatment of bone loss
EP4188372A1 (en)	2020-07-29	2023-06-07	Amryt Pharmaceuticals Inc.	Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
IL81325A (en) *	1986-01-23	1990-11-29	Merck Frosst Canada Inc	Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
CA1326030C (en) *	1987-07-21	1994-01-11	John W. Gillard	Cyclohept[b]indolealkanoic acids
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 EP EP95114877A patent/EP0705831B1/de not_active Expired - Lifetime
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 CA CA2159546A patent/CA2159546C/en not_active Expired - Fee Related
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active Expired - Fee Related
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 EE EE9500071A patent/EE03527B1/xx not_active IP Right Cessation
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL129641A0 (en)	2000-02-29
DE4435477A1 (de)	1996-04-11
NO953930L (no)	1996-04-09
HU225052B1 (en)	2006-05-29
HRP950505A2 (en)	1997-08-31
PT705831E (pt)	2004-04-30
JP3901234B2 (ja)	2007-04-04
SV1995000062A (es)	1996-07-10
IL115493A (en)	1999-10-28
US6265431B1 (en)	2001-07-24
NZ280130A (en)	1996-05-28
US20020147209A1 (en)	2002-10-10
SK123995A3 (en)	1996-06-05
IL115493A0 (en)	1996-01-19
PL183154B1 (pl)	2002-05-31
FI954681A0 (fi)	1995-10-02
CZ291348B6 (cs)	2003-02-12
US6858622B2 (en)	2005-02-22
CN1224715A (zh)	1999-08-04
NO953930D0 (no)	1995-10-03
CN1050605C (zh)	2000-03-22
KR960014126A (ko)	1996-05-22
MA23683A1 (fr)	1996-07-01
FI113048B (fi)	2004-02-27
SI0705831T1 (en)	2004-02-29
EP0705831A3 (de)	1997-01-22
EP0705831B1 (de)	2003-12-03
DK0705831T3 (da)	2004-04-05
TNSN95098A1 (fr)	1996-02-06
HN1995009160A (es)	2000-04-24
NO305365B1 (no)	1999-05-18
UA44700C2 (uk)	2002-03-15
JPH08225526A (ja)	1996-09-03
CA2159546C (en)	2010-12-14
EP0705831A2 (de)	1996-04-10
CN1183111C (zh)	2005-01-05
PL310756A1 (en)	1996-04-15
KR100355986B1 (ko)	2003-01-06
ATE255580T1 (de)	2003-12-15
SK284260B6 (sk)	2004-12-01
TW448175B (en)	2001-08-01
US5684014A (en)	1997-11-04
DE59510839D1 (de)	2004-01-15
ES2211890T3 (es)	2004-07-16
AU3292095A (en)	1996-04-18
EE9500071A (et)	1996-04-15
EE03527B1 (et)	2001-10-15
US20030149073A1 (en)	2003-08-07
AU700609B2 (en)	1999-01-07
HU9502891D0 (en)	1995-11-28
ZA958297B (en)	1996-05-06
CA2159546A1 (en)	1996-04-05
US20020055635A1 (en)	2002-05-09
DZ1934A1 (fr)	2002-02-17
SG63528A1 (en)	1999-03-30
FI108791B (fi)	2002-03-28
HK1005139A1 (en)	1998-12-24
US6479503B2 (en)	2002-11-12
FI954681A7 (fi)	1996-04-05
HUT73240A (en)	1996-07-29
PH31400A (en)	1998-10-29
HRP950505B1 (en)	2002-04-30
CZ256795A3 (en)	1996-04-17
IL129641A (en)	2000-08-31
MY117282A (en)	2004-06-30
RU2157803C2 (ru)	2000-10-20
US6245775B1 (en)	2001-06-12
CN1130631A (zh)	1996-09-11

Publication	Publication Date	Title
FI954739A7 (fi)	1995-12-05	Menetelmä etikkahapon valmistamiseksi
FI932515A7 (fi)	1993-12-03	Menetelmä etikkahapon valmistamiseksi
FI970648L (fi)	1997-04-07	Menetelmä nukleiinihappojen jakelemiseksi
ID19227A (id)	1998-06-28	Metoda memproduksi asam-asam karboksilat
FI923675L (fi)	1992-08-17	Menetelmä polyakryylihappojen valmistamiseksi
HUP0004337A3 (en)	2004-07-28	Method for producing 8-methoxy-quinoline carboxylic acids
FI20050181L (fi)	2005-02-16	Menetelmä valmistaa 21-kloorikortikosteroideja
DE69731727D1 (de)	2004-12-30	Verfahren zum herstellen von magnetischer verbundfolie
FI964525L (fi)	1998-05-12	Menetelmä polyhydroksihappojen valmistamiseksi
FI964001L (fi)	1996-10-04	Menetelmä 7-trialkyylisilyylibakkatiini III:n valmistamiseksi
FI920033A7 (fi)	1992-07-06	Menetelmä karboksyylihappojen puhdistamiseksi
FI953673L (fi)	1996-02-13	Menetelmä tioamidien valmistamiseksi
FI964121A7 (fi)	1996-10-14	Menetelmä amidokarboksyylihappojen valmistamiseksi vedessä
FI956233L (fi)	1996-06-30	Menetelmä aldehydien valmistamiseksi
FI940869A7 (fi)	1994-08-26	Menetelmä karboksyylihappoanhydridien valmistamiseksi
IL135434A0 (en)	2001-05-20	Method for preparing substituted 4-phenyl-4- cyanocyclohexanoic acids
EP0743935A4 (en)	1997-05-02	METHOD FOR PRODUCING CARBONIC ACIDS
FI963018A7 (fi)	1996-07-30	Menetelmä gammapyronien valmistamiseksi
FI954786L (fi)	1995-10-06	Menetelmä aminometaanifosfonihapon valmistamiseksi
IL131270A (en)	2005-05-17	Compounds and method for preparing substituted 4-phenyl-4-cyanocylohexanoic acids
FI950307L (fi)	1995-07-27	Menetelmä bisyklopentadienyyliyhdisteiden valmistamiseksi
ZA955462B (en)	1996-05-07	Process for preparing N-phosphonomethylamino carboxylic acids
FI964607L (fi)	1997-01-16	Menetelmä N-Z-suojattujen N-alkyloitujen aminohappojen valmistamiseksi
IL156265A0 (en)	2004-01-04	Compounds and method for preparing substituted 4-phenyl-4-cycanocyclohexanoic acids
SI1023279T1 (en)	2003-12-31	Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids